$OGEN still in a very solid position to take off and is undervalued at $1.32. Most covid biotech stocks were down Friday because the next 1-2 trillion stimulus stalled. If congress gets it thru this week, there will be 26 billion for vaccine research and 25 billion for testing. Oreganics will either release news on positive development such as BARDA funding or news on congress approval of next stimilus will be a catalyst for the next jump ($2.12 was last based on news from July 10). A Monday jump would be great, but I'm prepared that it might be a bumpy ride this week. Holding and buying more when I can given all the information. Every time it hits new highs, shorter and bears try to beat it down, but each time it goes back up because it's solid.
  • 8
8 Likes